
Recordati Industria Chimica e Farmaceutica S.p.A.
- Jurisdiction
Italy - LEI
815600FBF92FD3531704 - ISIN
IT0003828271 (REC.MI )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€53.76 5.4% undervalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. Read full profile
Stock price
Fundamentals
- Net revenue
€2.48B - Gross margin
67.8% - EBIT
€631.35M - EBIT margin
25.5% - Net income
€407.26M - Net margin
16.4%
Statement period: - (published )
Estimates
Fiscal Year | Net revenue | Net income |
---|---|---|
|
| |
|
| |
|
|
Dividends
- Last dividend amount
-
€0.67 - Ex date
-
- Payment date
-
- Dividend payout ratio
-
64.5%
Earnings Calls
Latest earnings call: November 8, 2024